UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 52

Sortiert nach

Oxidative metabolism drives inflammation-induced platinum resistance in human ovarian cancer

Cell death and differentiation, 2016-05, Vol.23 (9), p.1542-1554

2016

Volltextzugriff (PDF)

Oxidative metabolism drives inflammation-induced platinum resistance in human ovarian cancer

Cell death and differentiation, 2016-09, Vol.23 (9), p.1542-1554

2016

Volltextzugriff (PDF)

In vitro activity and in vivo efficacy of tigecycline alone and in combination with daptomycin and rifampin against Gram-positive cocci isolated from surgical wound infection

European journal of clinical microbiology & infectious diseases, 2012-08, Vol.31 (8), p.1759-1764

2012

Volltextzugriff (PDF)

In vitro activity of the lipopeptide derivative (Pal-lys-lys-NH2), alone and in combination with antifungal agents, against clinical isolates of dermatophytes

British journal of dermatology (1951), 2009-08, Vol.161 (2), p.249-252

2009

Volltextzugriff (PDF)

In vitro activity of the lipopeptide PAL-Lys-Lys-NH2, alone and in combination with antifungal agents, against clinical isolates of Candida spp

Peptides (New York, N.Y. : 1980), 2011, Vol.32 (1), p.99-103

2011

Volltextzugriff (PDF)

In vitro activity of Tachyplesin III alone and in combination with terbinafine against clinical isolates of dermatophytes

Peptides (New York, N.Y. : 1980), 2009-10, Vol.30 (10), p.1794-1797

2009

Volltextzugriff (PDF)

Interactions between Triazoles and Amphotericin B against Cryptococcus neoformans

Antimicrobial Agents and Chemotherapy, 2000-09, Vol.44 (9), p.2435-2441

2000

Volltextzugriff (PDF)

In Vitro Activity of Posaconazole against Clinical Isolates of Dermatophytes

Journal of Clinical Microbiology, 2001-11, Vol.39 (11), p.4208-4209

2001

Volltextzugriff (PDF)

Primary resistance to flucytosine among clinical isolates of Candida spp

Journal of antimicrobial chemotherapy, 2000-03, Vol.45 (3), p.408-409

2000

Volltextzugriff (PDF)

In-vitro interaction of terbinafine with amphotericin B, fluconazole an itraconazole against clinical isolates of Candida albicans

Journal of antimicrobial chemotherapy, 1998, Vol.41 (1), p.59-65

1998

Volltextzugriff (PDF)

In-Vitro Activity of the Synthetic Protegrin IB-367 Alone and in Combination with Antifungal Agents Against Clinical Isolates of Candida spp

Journal of chemotherapy (Florence), 2007-10, Vol.19 (5), p.514-518

2007

Volltextzugriff (PDF)

Genotyping and antifungal susceptibility of human subgingival Candida albicans isolates

Archives of oral biology, 2002-03, Vol.47 (3), p.189-196

2002

Volltextzugriff (PDF)

Comparison of the Fungicidal Activities of Caspofungin and Amphotericin B against Candida glabrata

Antimicrobial Agents and Chemotherapy, 2005-12, Vol.49 (12), p.4989-4992

2005

Volltextzugriff (PDF)

Epidemiology of onychomycosis and paronychia in the area of ANCONA (ITALY) over a period of 5 years

Mycopathologia (1975), 2004-10, Vol.158 (3), p.271-274

2004

Volltextzugriff (PDF)

Infection due to Absidia corymbifera in a patient with a massive crush trauma of the foot

The Journal of infection, 1999-05, Vol.38 (3), p.191-192

1999

Volltextzugriff (PDF)

Fluconazole susceptibility and strain variation of Candida albicans isolates from HIV-infected patients with oropharyngeal candidosis

Journal of antimicrobial chemotherapy, 1998-05, Vol.41 (5), p.541-548

1998

Volltextzugriff (PDF)

Genotypic identification of sequential Candida albicans isolates from AIDS patients by polymerase chain reaction techniques

European journal of clinical microbiology & infectious diseases, 1997-08, Vol.16 (8), p.601-605

1997

Volltextzugriff (PDF)

Electrophoretic karyotyping and triazole susceptibility of Candida glabrata clinical isolates

European journal of clinical microbiology & infectious diseases, 1999-03, Vol.18 (3), p.184-187

1999

Volltextzugriff (PDF)

Caspofungin in Combination with Amphotericin B against Candida glabrata

Antimicrobial Agents and Chemotherapy, 2005-06, Vol.49 (6), p.2546-2549

2005

Volltextzugriff (PDF)

In vitro activity of terbinafine against clinical isolates of dermatophytes

Medical mycology (Oxford), 1998-08, Vol.36 (4), p.235-237

1998

Volltextzugriff (PDF)

In Vitro Activities of the New Antifungal Triazole SCH 56592 against Common and Emerging Yeast Pathogens

Antimicrobial Agents and Chemotherapy, 2000-01, Vol.44 (1), p.226-229

2000

Volltextzugriff (PDF)

Point prevalence, microbiology and fluconazole susceptibility patterns of yeast isolates colonizing the oral cavities of HIV-infected patients in the era of highly active antiretroviral therapy

Journal of antimicrobial chemotherapy, 2002-12, Vol.50 (6), p.999-1002

2002

Volltextzugriff (PDF)

Trichosporon beigelii fungaemia in an AIDS patient

AIDS (London), 1993-01, Vol.7 (1), p.139-140

1993

Volltextzugriff (PDF)

Electrophoretic karyotyping and antifungal susceptibility patterns of Candida parapsilosis clinical isolates causing deep and superficial fungal infections

Mycopathologia (1975), 2001-01, Vol.149 (3), p.117-121

2001

Volltextzugriff (PDF)

Sequential Therapy with Caspofungin and Fluconazole for Candida albicans Infection

Antimicrobial Agents and Chemotherapy, 2004-10, Vol.48 (10), p.4056-4058

2004

Volltextzugriff (PDF)

1 – 25 von 52

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(48)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(34)
Science & Technology
(34)
Biological And Medical Sciences
(30)
Humans
(30)
Medical Sciences
(28)
Antifungal Agents - Pharmacology
(26)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(22)
Antifungal Agents
(22)
Pharmacology. Drug Treatments
(22)
Microbial Sensitivity Tests
(21)
Infectious Diseases
(20)
Microbiology
(19)
Pharmacology & Pharmacy
(17)
Aids/hiv
(12)
Female
(12)
Male
(11)
Fluconazole - Pharmacology
(10)
Candida - Drug Effects
(9)
Mycology
(9)
Adult
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Oxidative metabolism drives inflammation-induced platinum resistance in human ovarian cancer

Oxidative metabolism drives inflammation-induced platinum resistance in human ovarian cancer

In vitro activity and in vivo efficacy of tigecycline alone and in combination with daptomycin and rifampin against Gram-positive cocci isolated from surgical wound infection

In vitro activity of the lipopeptide derivative (Pal-lys-lys-NH2), alone and in combination with antifungal agents, against clinical isolates of dermatophytes

In vitro activity of the lipopeptide PAL-Lys-Lys-NH2, alone and in combination with antifungal agents, against clinical isolates of Candida spp

In vitro activity of Tachyplesin III alone and in combination with terbinafine against clinical isolates of dermatophytes

Interactions between Triazoles and Amphotericin B against Cryptococcus neoformans

In Vitro Activity of Posaconazole against Clinical Isolates of Dermatophytes

Primary resistance to flucytosine among clinical isolates of Candida spp

In-vitro interaction of terbinafine with amphotericin B, fluconazole an itraconazole against clinical isolates of Candida albicans

In-Vitro Activity of the Synthetic Protegrin IB-367 Alone and in Combination with Antifungal Agents Against Clinical Isolates of Candida spp

Genotyping and antifungal susceptibility of human subgingival Candida albicans isolates

Comparison of the Fungicidal Activities of Caspofungin and Amphotericin B against Candida glabrata

Epidemiology of onychomycosis and paronychia in the area of ANCONA (ITALY) over a period of 5 years

Infection due to Absidia corymbifera in a patient with a massive crush trauma of the foot

Fluconazole susceptibility and strain variation of Candida albicans isolates from HIV-infected patients with oropharyngeal candidosis

Genotypic identification of sequential Candida albicans isolates from AIDS patients by polymerase chain reaction techniques

Electrophoretic karyotyping and triazole susceptibility of Candida glabrata clinical isolates

Caspofungin in Combination with Amphotericin B against Candida glabrata

In vitro activity of terbinafine against clinical isolates of dermatophytes

In Vitro Activities of the New Antifungal Triazole SCH 56592 against Common and Emerging Yeast Pathogens

Point prevalence, microbiology and fluconazole susceptibility patterns of yeast isolates colonizing the oral cavities of HIV-infected patients in the era of highly active antiretroviral therapy

Trichosporon beigelii fungaemia in an AIDS patient

Electrophoretic karyotyping and antifungal susceptibility patterns of Candida parapsilosis clinical isolates causing deep and superficial fungal infections

Sequential Therapy with Caspofungin and Fluconazole for Candida albicans Infection

Suchergebnisse filtern